Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shorter weaning from invasive ventilation with levosimendan
2024-518810-23-00Phase 4Authorised
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levosimendan in Weaning failure (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Ventilator-free days to day 28. Planned start Sep 2025; status: authorised.
02
Drugs
levosimendan
03
Conditions
Weaning failure
Beyond the preview
Go deeper on 2024-518810-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518810-23-00.